Noticias SiNtx Technologies Inc - SINT | Acciones NASDAQ

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Form 8-K - Current report

SINTX Technologies Secures Patent Allowance for Wide-Ranging Silicon Nitride Biomaterial Applications

Salt Lake City, Utah, Dec. 17, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or...

Form 8-K - Current report

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

Salt Lake City, UT, Nov. 21, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the...

Form 8-K - Current report

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

Seasoned Healthcare Executive to Lead Strategic Growth Initiatives Salt Lake City, UT, Nov. 19, 2024 (GLOBE...

Form 8-K - Current report

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form DEF 14A - Other definitive proxy statements

SINTX Technologies Provides Positive Strategic Business Update for Q3 2024

Salt Lake City, UT, Nov. 14, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

Salt Lake City, Utah, Oct. 01, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or...

boston745 10 horas hace

Got to hand it to those anonymous posters on Cafepharma right Pitk17/SnoopyDog? 👏:

Paragon 28
Thread starter anonymous Start date Apr 17, 2024
Will ZB purchase ...or Stryker beat them to it ?
Also posted at Cafepharma:

anonymous Jul 22, 2015 at 09:35: PM
Word on the street is a merger/buyout with Amedica....any info or thoughts?
Meanwhile this was an excellent quote from that thread...sound familiar?

In general growth is name of the game. Both paragon 28 and Treace are purposely staying unprofitable with a heavy emphasis on investment in r&d &/or commercial channel to drive revenue.

You only get one shot to flip to profitable so you better have commercial channel &/or bag filled.
In almost every way this describes Sintx. Difference being Sintx didnt invest in a sales channel but developing multiple product lines and partnerships to help bring those products to market.

Just like you'll see here, this was posted usually by Joev2:
no "heavy emphasis on investment" anywhere in the organization, just pure incompetence at running a company or managing finances.
He ain’t lying. Look at sintx threads on Zimmer. A horribly ran company that has 10k, 10q and analyst reviews that can show no debt and analyst say buy. But in reality, sintx all forward look statements, all BS fluff PR’s. Management has zero clue, just collecting checks. This happens all over the place. One of the 2 named companies is more then likely a god damn disaster like sintx.
For some reason...someone brought Sintx into the conversation but the post was ignored.

Quote Sources:
https://www.cafepharma.com/boards/threads/paragon-28.699211/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=131898427

========================================

For continued coverage of significant Airplane malfunctions and why Sintx Si3N4 aerospace products are needed goto my research board. 42 passenger plane malfunctions since December 22nd..
https://investorshub.advfn.com/Bostons-research-43724

Here is a collection of my research going over multiple subjects including Sintx connections with Zimmer Biomet, Solventum, Morgan Ceramics, & NP Aerospace. Includes other research topics as well.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175357996

========================================

We already know Sintx and Morgan were working together. If there is going to be some sort of NP/Sintx merger, that just solidifies it. We also know Zimmer Biomet and Sintx have had a long standing relationship (going on 20 years) so as long as Sintx components for Arthroplasty are any good, Zimmer Biomet will come out from behind the curtain. With ZB comes ZimVie and I believe Solventum because of Bryan Hanson. Leaving only Cardinal Health which is suggested by Sintx hiring of Joseph Palomo who joined Sintx from Cardinal Health R&D division.

Morgan Ceramics = Aerospace products
Zimmer Biomet = Arthroplasty oriented products
ZimVie = Dental?
Solventum = Wound Care, Catheters, & possibly Cancer treatment products.
Ned Medical = Microspheres for cancer treatment
Cardinal Health = PPE & Medical protection apparel.
NP Aerospace = Armor plates & other possible products connected to TA&T.

========================================

Markets Si3n4/Sintx Ceramics can be used in (not comprehensive)

Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Cancer Treatment (microspheres) = $5-$15bn

Total = $330bn-340bn

Sources:
https://web.archive.org/web/2024040...ogger.blogspot.com/2011/05/whos-next.html?m=1
https://orthospinenews.com/2021/01/...y-2025-as-acquisitions-surge-says-globaldata/
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
https://www.youtube.com/watch?v=KeSa5vCj6Kw
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
https://www.youtube.com/watch?v=KeSa5vCj6Kw

👍️0

jimr1717 12 horas hace

For the Longest time I have found that

I can’t stop pounding the table

on the exact same thing.

👍️0

boston745 15 horas hace

For the longest time i have wondered why Sintx was pursuing Foot & Ankle based products over the years, going back many years. It could have left this sort of development until they had a commercial partner for its Spine/Hip&Knee tech. Today that pursuit makes more sense and implies this alignment is part of a long-term plan. You'd have to goto my research board to see all the connections between Sintx and Zimmer Biomet to better understand my statement. Section 2 of this post has direct link to that research.
Sintx and NedMedical have larger market potential than Paragon 28, but Paragon has established sales akin to LDR which turned out to be a bad investment for ZB. If they combine Sintx patented coating tech with Paragon's tech, maybe this acquisition will not be as bad?

https://i.imgur.com/vTjjL1u.jpeg

Demonstrates Zimmer Biomet's Commitment to Investing in Higher Growth
End-Markets, with Expansion into ~$5 Billion Foot and Ankle Segment
Paragon 28, Inc. (NYSE: FNA), a leading medical device company focused exclusively on the foot and ankle orthopedic segment, today announced they have entered into a definitive agreement for Zimmer Biomet to acquire all outstanding shares of common stock of Paragon 28

Quote Sources:
https://d1io3yog0oux5.cloudfront.net/_4b06359e4ac08cf109f39d71f40349db/sintx/db/443/4298/pdf/SINTX+Corporate+Overview+-+Jan+%2724+-+Rev+J.pdf
https://www.prnewswire.com/news-releases/zimmer-biomet-announces-definitive-agreement-to-acquire-paragon-28-302362653.html

========================================

For continued coverage of significant Airplane malfunctions and why Sintx Si3N4 aerospace products are needed goto my research board. 42 passenger plane malfunctions since December 22nd. Yesterday a passenger plane literally caught fire at the rear of the plane while initiating pre-takeoff procedures. Pretty scary incident.
https://investorshub.advfn.com/Bostons-research-43724

Here is a collection of my research going over multiple subjects including Sintx connections with Zimmer Biomet, Solventum, Morgan Ceramics, & NP Aerospace. Includes other research topics as well.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175357996

========================================

We already know Sintx and Morgan were working together. If there is going to be some sort of NP/Sintx merger, that just solidifies it. We also know Zimmer Biomet and Sintx have had a long standing relationship (going on 20 years) so as long as Sintx components for Arthroplasty are any good, Zimmer Biomet will come out from behind the curtain. With ZB comes ZimVie and I believe Solventum because of Bryan Hanson. Leaving only Cardinal Health which is suggested by Sintx hiring of Joseph Palomo who joined Sintx from Cardinal Health R&D division.

Morgan Ceramics = Aerospace products
Zimmer Biomet = Arthroplasty oriented products
ZimVie = Dental?
Solventum = Wound Care, Catheters, & possibly Cancer treatment products.
Ned Medical = Microspheres for cancer treatment
Cardinal Health = PPE & Medical protection apparel.
NP Aerospace = Armor plates & other possible products connected to TA&T.

========================================

Markets Si3n4/Sintx Ceramics can be used in (not comprehensive)

Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Cancer Treatment (microspheres) = $5-$15bn

Total = $330bn-340bn

Sources:
https://web.archive.org/web/2024040...ogger.blogspot.com/2011/05/whos-next.html?m=1
https://orthospinenews.com/2021/01/...y-2025-as-acquisitions-surge-says-globaldata/
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
https://www.youtube.com/watch?v=KeSa5vCj6Kw
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
https://www.youtube.com/watch?v=KeSa5vCj6Kw

👍️0

jimr1717 17 horas hace

These are all very good points. However I see no reason that all of this couldn’t be accomplished with 2 or 3 more Reverse Splits.
I would also add that adding bonuses of 3 or 4 times to the current employee’s bonuses along with a few million gifted shares might be an incentive to accomplish this by 2096.

👍️0

PioneerPhoenix73 18 horas hace

While I appreciate your enthusiasm to believe that the 'Moon Is Made of Cheese' hypothesis, my professional endeavours necessitate a grounded approach. I prioritize evidence-based conclusions and rely on verifiable data, eschewing speculative narratives, unsubstantiated claims, pseudo sciences and conspiracy theories

Here are some reasons why the claimed total addressable markets (TAMs) for Sintx Si3N4 ceramics might be inflated or completed fabricated

Technical challenges: While the study shows promise for 3D-printed PEEK/silicon nitride scaffolds for spinal fusion implants, large scale production with consistent quality may be difficult and expensive.

Regulatory hurdles: Regulatory approval for new medical devices can be a long and complex process, which could delay or even prevent Sintx from bringing its products to market.

Competition: Existing players in the market for spinal fusion implants and other applications may be difficult to displace. Sintx would need to demonstrate that its products offer significant advantages over existing options.

Focus on a niche market: The study focuses on spinal fusion implants, which is a relatively small market compared to some of the other markets that are mentioned, such as the condom market or the wound care market. It is possible that Sintx will not be able to achieve the level of sales that is being projected.
It's important to remember that these are just some of the potential challenges that Sintx could face. The company may be able to overcome these challenges and achieve its ambitious goals. However, it is important to be aware of the risks involved before investing in Sintx or any other company.

Here are some additional points to consider:

The cited sources for the TAM estimates are not all from reputable sources. Some are from blog posts or investor forums, which may not be reliable sources of information.

The TAM estimates seem to be based on the assumption that Sintx's products will be successful in all of the markets that are mentioned. This is a very optimistic assumption.

The TAM estimates do not take into account the costs of developing and marketing Sintx's products.
Overall, it is important to be skeptical of the claims about the TAM for Sintx's products.

The company may face a number of challenges in bringing its products to market, and the TAM estimates may be inflated or fabricated.

👍️0

boston745 1 día hace

3D-Printed PEEK/Silicon Nitride Scaffolds with a Triply Periodic Minimal Surface Structure for Spinal Fusion Implants

In the present study, we found that the elastic moduli of PEEK/SiN TPMS scaffolds with 30% porosity fell within the same range as human cancellous bone.
When the elastic modulus of an implant material closely matches that of human bone, it can help minimize the detrimental effects of stress shielding. By closely resembling the mechanical properties of the surrounding bone, the implant can distribute mechanical forces more uniformly, enabling the bone to bear its intended load. This characteristic is vital in maintaining the structural integrity of the bone and preventing excessive bone resorption or weakening.34 Additionally, the absence of stress shielding effects facilitates optimal stress distribution, which promotes bone cell attachment and growth around the implant, potentially enhancing osseointegration.3
Therefore, the PEEK/SiN TPMS scaffold limits the risk of implant failure and has demonstrated sufficient loadbearing capacity to function as a substitute for trabecular vertebral bone.
In conclusion, the mechanical and biological tests demonstrated that PEEK/SiN TPMS scaffolds hold promise for use as spinal fusion implants and in bone tissue engineering applications. In the future, additional efforts should focus on increasing the silicon nitride content in PEEK to achieve better osteogenic response while maintaining the mechanical properties of PEEK.
Looks like this was the data used to demonstrate the effectiveness so Sintx could be awarded Phase II grant

SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

“In Phase II, SINTX and external collaborators will conduct formal design validation activities; test static and dynamic mechanical properties of implants 3DP according to the revised design; carry out formal biocompatibility assessments; and assess in vivo antimicrobial activity, biocompatibility, and osseointegration for a 3DP SN-PEEK cervical implant against appropriate controls.”

SINTX will collaborate with the University of Pennsylvania School of Veterinary Medicine (Penn Vet) over the next 24 months to execute this project.
Upon the successful execution of the Phase II grant application goals, SINTX will have the majority of the benchtop and large animal in vivo data needed to seek FDA regulatory clearance using the 510(k) pathway. Additionally, successful demonstration of infection prevention in vivo will be a critical step towards enabling an antimicrobial device claim. These preliminary animal data will be used to seek future funding from NIH or other Federal agencies to further validate antimicrobial properties of devices made from SN-PEEK.
After/assuming successful results, they'll have the data needed for FDA submission and the ability to validate their claims of antimicrobial of SN-PEEK composite implants. As Sintx cannot move forward with commercializing this alone, they'll need their strategic partners to step up! I'd expect some sort of collaboration announced this year if the results are sufficient. This could be one of the reasons for the various moves they have done to prep for a move of the stock. Maybe we'll finally see some real tute investment beforehand?

Quote Sources:
https://pubs.acs.org/doi/10.1021/acsabm.3c00383
https://ir.sintx.com/news-events/press-releases/detail/216/sintx-technologies-awarded-phase-ii-nih-grant-for-silicon

========================================

For continued coverage of significant Airplane malfunctions and why Sintx Si3N4 aerospace products are needed goto my research board. 40 passenger plane malfunctions since December 22nd. Just today one passenger plane caught fire while going through pre-takeoff. Pretty scary stuff!
https://investorshub.advfn.com/Bostons-research-43724

Here is a collection of my research going over multiple subjects including Sintx connections with Zimmer Biomet, Solventum, Morgan Ceramics, & NP Aerospace. Includes other research topics as well.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175357996

========================================

We already know Sintx and Morgan were working together. If there is going to be some sort of NP/Sintx merger, that just solidifies it. We also know Zimmer Biomet and Sintx have had a long standing relationship (going on 20 years) so as long as Sintx components for Arthroplasty are any good, Zimmer Biomet will come out from behind the curtain. With ZB comes ZimVie and I believe Solventum because of Bryan Hanson. Leaving only Cardinal Health which is suggested by Sintx hiring of Joseph Palomo who joined Sintx from Cardinal Health R&D division.

Morgan Ceramics = Aerospace products
Zimmer Biomet = Arthroplasty oriented products
ZimVie = Dental?
Solventum = Wound Care, Catheters, & possibly Cancer treatment products.
Ned Medical = Microspheres for cancer treatment
Cardinal Health = PPE & Medical protection apparel.
NP Aerospace = Armor plates & other possible products connected to TA&T.

========================================

Markets Si3n4/Sintx Ceramics can be used in (not comprehensive)

Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Cancer Treatment (microspheres) = $5-$15bn

Total = $330bn-340bn

Sources:
https://web.archive.org/web/2024040...ogger.blogspot.com/2011/05/whos-next.html?m=1
https://orthospinenews.com/2021/01/...y-2025-as-acquisitions-surge-says-globaldata/
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
https://www.youtube.com/watch?v=KeSa5vCj6Kw
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
https://www.youtube.com/watch?v=KeSa5vCj6Kw

👍️0

jimr1717 1 día hace

I am most optimistic that this is why you won’t find any institutional holders in this Fake it scam.
If there are, they are exposed to minimal risk by owning very little.

The smoke and mirrors in this pos are easy enough for even the blind to see.

“ ceramic teeth”
This might be the best for those that chose to eat tide pods.

👍️0

jimr1717 2 días hace

While I’m optimistic on a near future Reverse Split I don’t see why Fake It Scams like this are not just Revoked.

👍 1 🔥 1

boston745 2 días hace

👍️0

PioneerPhoenix73 2 días hace

Just to sum up, they have partnerships in place..."

Oh, partnerships! Those magical agreements where one company does all the work, bears all the risk, and the other company gets to reap the rewards. Pure altruism, I tell you.

"face masks, filters, wound care..."

Face masks! The cutting edge of medical technology! Who knew that a company specializing in advanced ceramics could revolutionize the humble face mask? And filters! So groundbreaking! I'm sure they're filtering out those pesky thoughts of impending bankruptcy.

"coatings (likely for ortho but other possible uses as well)..."

"Likely." Such scientific certainty! It's like saying, "I might win the lottery tomorrow."

"Female body Armor..."

Ah, the chivalry! Protecting the fairer sex with...ceramics? I'm sure it's incredibly comfortable and fashionable.

"Cancer Treatment..."

A noble pursuit! Though, I wonder if their ceramic-based chemotherapy will have fewer side effects than, you know, actual chemotherapy.

"Catheter Coating..."

Preventing those pesky urinary tract infections with...ceramic? Sounds delightful.

"dental implants..."

Because who wouldn't want to have a mouthful of ceramic teeth?

"Renewed interest in Hip components..."

"Renewed interest." A euphemism for "still trying to figure out how to make this work."

"Aerospace component partner with a small 8m contract in place."

Eight million dollars! That's practically enough to buy a decent used car.

"They also have partners, one currently selling Si3N4 spinal implants..."

Selling? As in, actually generating revenue? Now that's a novel concept.

"and they have commercial partners helping them develop Si3N4/PEEK implants."

"Helping them develop." Translation: "We're hoping they'll figure it out eventually."

"Whats odd is how almost all their partnerships are cloaked by NDAs..."

"Cloaked." Because transparency is for suckers.

"This allows those posters that pretend to be bearish to act like Sintx is less likely to be successful than it is."

Ah, the classic "blame the critics" strategy.

"Multiple partnerships, multiple potential revenue generating product lines..."

"Potential." That magical word that keeps delusional investors afloat.

"At anypoint, if one or more of those partners (the larger ones) steps forward..."

"If." A word that should be tattooed on the forehead of every Sintx investor.

"then SINT skyrockets."

Skyrockets? More like nosedives.

"Until then its a waiting game."

A waiting game that could last longer than the lifespan of the universe.

"But SINT is insanely undervalued at a marketcap of around 3m."

Insanely undervalued? Or perhaps insanely overvalued given its track record of abject failure?

There you have it. A dose of cold, hard reality to counterbalance the rampant optimism. Now go forth and invest wisely (or not).

👍️0

jimr1717 2 días hace

Just to sum up, For the 11th straight year it would appear that Mr Market hasn’t fallen for this Fake it and Never make it Scam.

👍️0

jimr1717 2 días hace

It’s almost Two Buck Tuesday again

👍️0

boston745 3 días hace

👍️0

PioneerPhoenix73 3 días hace

I am not satisfied because you did not answer my 2 questions. So get some astro glide and let's try this again !

I find it deeply concerning that Sintx Technologies, despite over 20 years of development in silicon nitride, has yet to achieve a single commercial sale. This persistent failure, coupled with the company's apparent reliance on government grants and bursaries as its primary source of revenue, raises serious questions about the viability and value of their intellectual property.

Furthermore, your continued engagement in conspiracy theories, reliance on anecdotal evidence, and fabrication of stories and addressable markets is unacceptable. These unsubstantiated claims, often unrelated to the topic at hand, lack any credible supporting links and undermine the credibility of your assertions.

Given the lack of commercial success and the apparent reliance on public funding, it is my professional opinion that Sintx Technologies may be insolvent and should be subject to a thorough financial and operational audit. This will determine the true value of their intellectual property and assess the company's ability to operate as a sustainable and profitable entity.

👍️0

boston745 3 días hace

10k does indicate several partners but is limited on what products they are working with partner. So helps to view the companies Jan 2024 presentation.

We have several partnerships exploring opportunities in face masks, filters, wound care, and coatings.
Pg 10 10k
Face Masks could be with Cardinal Health and/or Solventum. Not sure whats taking so long to announce a partnership on this product as they already imbued Si3N4 into fabrics.
Wound Care i would think would be with Solventum.
Coatings is too ambiguous but i'd bet Zimmer Biomet is one of the partners on this product, depending on what the coating is being applied to. Zimmer Biomet hired Dr. Saraubh Lal an expert in Si3n4 coating testing.
Tesla should be, but there is no evidence it is, exploring Si3N4 coatings to see if it could help reduce its Hutchison Effect causing Teslas Whompy Wheel issue.

We are developing female-specific torso plates with a partner and expect this market to grow. We also have early-stage relationships with integrators for body armor and aircraft armor. Pg 11
This one is pretty straight forward, they were working on this with NP Aerospace as NP in parallel fashion is also working on female specific armor. Both companies connected via Morgan Ceramics and Donald Bray who was head of the NP division before Morgan sold it.

Several new collaborations in developing products for wound care, cancer treatment, and an antipathogenic coating for catheters.
Working with dental implant companies to supply novel silicon nitride implants
Renewed interest in silicon nitride’s use as a femoral head and acetabular cup.
Wound care is mentioned in the 10k, Cancer Treatment has been revealed to be working with at least Ned Medical but could include Solventum as well.Coatings are also mentioned in the 10k. As you can see they have one or more dental partnerships which at one time, at least, included Dentsply.
Lastly renewed interest in its femoral head and acetabular cup implies ZImmer Biomet as thats the most recent company theyve partnered with in regards to hip implant components
Solvenetum and Sintx working together is based on the fact that its CEO was Zimmer Biomet's CEO who would be well aware of Sintx technology and if it could benefit 3M's medical division spin-off.

Quote Sources:
https://www.sec.gov/ix?doc=/Archives/edgar/data/1269026/000149315224011546/form10-k.htm
https://d1io3yog0oux5.cloudfront.net/_4b06359e4ac08cf109f39d71f40349db/sintx/db/443/4298/pdf/SINTX+Corporate+Overview+-+Jan+%2724+-+Rev+J.pdf

=======================================

Hutchison Effect is a real phenomenon and can Sintx Si3N4 disrupt the effect?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175690086&txt2find=Hutchison

Hutchison Effect & Teslas Whompy Wheel issue

Jain is one of tens of thousands of Tesla owners who have experienced premature failures of suspension or steering parts, according to a Reuters review of thousands of Tesla documents. The chronic failures, many in relatively new vehicles, date back at least seven years and stretch across Tesla’s model lineup and across the globe, from China to the United States to Europe, according to the records and interviews with more than 20 customers and nine former Tesla managers or service technicians.

https://www.reuters.com/investigates/special-report/tesla-musk-steering-suspension/

The exact cause of the Hutchison Effect is unknown in public spheres as it is classified under national security. However the most likely culprit seems to be a combination of electromagnetic sources coming together in a way to change the makeup of metals leading to their rusting, softening, fracturing, complete breaking, even dustification. Keep in mind the degree of metal materials that are within our buildings and infrastructure...even in concrete. Maybe this is why we are seeing an increase in building and bridge collapses?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175056420

👍️0

boston745 3 días hace

👍️0

joev2 4 días hace

I think it's the greatest thing since the invention of the wheel. Satisfied? Of course not, because the ONLY thing you want from me and others is to agree with the scenario you portray: a scenario I don't even think is worth contemplating, since management and all these 'partnerships' don't. Like I said earlier, petty salaries, ego tripping among companies (and governments), along with a little slice of conspiracy games brings us to where we're at after all these years (instead of making [apparently] hundreds of millions and even billions while helping mankind)???? I don't think so. What it does show is the heart of a scam play and you bought fully in. Unlike most though, you can't admit you got it wrong. Sad....
Now i asked a question and you didnt answer the question but sidestepped it. So lets try this again, what do you think about Titanium being a Neurotoxin and the need to coat it/replace it with Si3N4?

👍️0

boston745 4 días hace

Yes i am aware you feel this way, its about the only thing you say. My counterpoint to that, other than the IP is badly needed by the industry, is that Sintx leadership are not on their own. They receive outside guidance from companies like Zimmer Biomet, Morgan Ceramics, & Cardinal Health, just to name a few. They have the product and some significant partners to potentially bring those products to market. Of course you ignore their partners, act like they dont exist, and that Sintx is all alone. However Sintx model of business depends on its partnerships for commercialization and one need review the 10k's to see they have several.

I DO NOT BELIEVE ANY of the people who were or ARE in leadership are CAPABLE to make the company a success.....meaning they don't have the capacity to bring the company to the next level (even IF leadership is honest, forthright and abounding in integrity)

Now i asked a question and you didnt answer the question but sidestepped it. So lets try this again, what do you think about Titanium being a Neurotoxin and the need to coat it/replace it with Si3N4?

Potential neurotoxicity of titanium implants: Prospective, in-vivo and in-vitro study

Titanium dioxide (TiO2) is a frequently used biomaterial, particularly in orthopedic and dental implants, and it is considered an inert and benign compound. This has resulted in toxicological scrutiny for TiO2 in the past decade, with numerus studies showing potential pathologic downstream effects. Herein we describe case report of a 77-year-old male with subacute CNS dysfunction, secondary to breakdown of a titanium-based carotid stent and leading to blood levels 1000 times higher (3 ppm) than the reported normal.

Rats bearing titanium implants or intravascularly treated with TiO2 nanoparticles (TiNP) exhibited memory impairments. A human blood-brain barrier (BBB) in-vitro model exposed to TiNP showed paracellular leakiness, which was corroborated in-vivo with the decrease of key BBB transcripts in isolated blood vessels from hippocampi harvested from TiNP-treated mice. Titanium particles rapidly internalized into brain-like endothelial cells via caveolae-mediated endocytosis and macropinocytosis and induced pro-inflammatory reaction with increased expression of pro-inflammatory genes and proteins. Immune reaction was mediated partially by IL-1R and IL-6. In summary, we show that high levels of titanium accumulate in humans adjacent to orthopedic implants, and our in-vivo and in-vitro studies suggest it may be neurotoxic.
Quote Source:
https://www.sciencedirect.com/science/article/abs/pii/S0142961221003951

I keep pounding the table on Sintx coating being needed, at the very least, to reduce the amount of corrosive metal ions released peoples bodies from metal implants. Personally i say screw the coating and just go full Si3N4 implant! However a coating is better than nothing. Coating method Sintx has allows them to coat companies current inventory if the FDA cleared it.
On a different note, 3 more passenger planes experiences glitching on the 24th bring the total passenger plane emergency landings/crashes to 34 since December 22nd. 35th incident occurred on the 25th.

Electromagnetic fields, metal implant corrosion, and dis-ease it causes

https://i.imgur.com/nLg7SXT.jpg

Cancer-Causing Effects of Orthopaedic Metal Implants in Total Hip Arthroplasty
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011042/

Oral Cancer around Dental Implants: Are the Clinical Manifestations and the Oncogenic Mechanisms Unique?
https://www.intechopen.com/chapters/79298

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779

========================================

For continued coverage of significant Airplane malfunctions and why Sintx Si3N4 aerospace products are needed goto my research board. 35 passenger plane malfunctions since December 22nd.
https://investorshub.advfn.com/Bostons-research-43724

Here is a collection of my research going over multiple subjects including Sintx connections with Zimmer Biomet, Solventum, Morgan Ceramics, & NP Aerospace. Includes other research topics as well.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175357996

========================================

We already know Sintx and Morgan were working together. If there is going to be some sort of NP/Sintx merger, that just solidifies it. We also know Zimmer Biomet and Sintx have had a long standing relationship (going on 20 years) so as long as Sintx components for Arthroplasty are any good, Zimmer Biomet will come out from behind the curtain. With ZB comes ZimVie and I believe Solventum because of Bryan Hanson. Leaving only Cardinal Health which is suggested by Sintx hiring of Joseph Palomo who joined Sintx from Cardinal Health R&D division.

Morgan Ceramics = Aerospace products
Zimmer Biomet = Arthroplasty oriented products
ZimVie = Dental?
Solventum = Wound Care, Catheters, & possibly Cancer treatment products.
Ned Medical = Microspheres for cancer treatment
Cardinal Health = PPE & Medical protection apparel.
NP Aerospace = Armor plates & other possible products connected to TA&T.

========================================

Markets Si3n4/Sintx Ceramics can be used in (not comprehensive)

Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Cancer Treatment (microspheres) = $5-$15bn

Total = $330bn-340bn

Sources:
https://web.archive.org/web/2024040...ogger.blogspot.com/2011/05/whos-next.html?m=1
https://orthospinenews.com/2021/01/...y-2025-as-acquisitions-surge-says-globaldata/
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
https://www.youtube.com/watch?v=KeSa5vCj6Kw
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
https://www.youtube.com/watch?v=KeSa5vCj6Kw

👍️0

joev2 5 días hace

We recently had an election. The result was the majority of voters believed one candidate could do the job better than the other. I say that to say this: regardless of ALL the potential Sint has I DO NOT BELIEVE ANY of the people who were or ARE in leadership are CAPABLE to make the company a success.....meaning they don't have the capacity to bring the company to the next level (even IF leadership is honest, forthright and abounding in integrity)....thus the comparison to the election results....except here in Sintland we have no real say. You and I have played this tune many times.....
Now what do you think about Titanium being a Neurotoxin and the need to coat it/replace it with Si3N4

👍️0

boston745 5 días hace

Sonny's not CEO/CFO anymore Joe. Olson would be hiring people and he isnt qualified to be a CFO if the company is going to grow. Sonny was qualified. The company was more successful than you're implying which is why it has such valuable IP. At any point, if one of its large partners steps out into the light making the partnership public instead of hidden behind NDAs, SINT shoots past Lind's $50 strike price warrants that expire in August because the IP is worth that much.

They will not PR the HR manager if that position was filled which is more likely a promotion from within. However CFO they'd have bring from outside the company most likely. If they hired one and thats why the pulled the position/it expired on LinkedIn after the two week period, then we should get a PR. That said, we may not see a PR until its more formal...could just be a gentleman's agreement until the person is available to start.

Now what do you think about Titanium being a Neurotoxin and the need to coat it/replace it with Si3N4

Potential neurotoxicity of titanium implants: Prospective, in-vivo and in-vitro study

Titanium dioxide (TiO2) is a frequently used biomaterial, particularly in orthopedic and dental implants, and it is considered an inert and benign compound. This has resulted in toxicological scrutiny for TiO2 in the past decade, with numerus studies showing potential pathologic downstream effects. Herein we describe case report of a 77-year-old male with subacute CNS dysfunction, secondary to breakdown of a titanium-based carotid stent and leading to blood levels 1000 times higher (3 ppm) than the reported normal.

Rats bearing titanium implants or intravascularly treated with TiO2 nanoparticles (TiNP) exhibited memory impairments. A human blood-brain barrier (BBB) in-vitro model exposed to TiNP showed paracellular leakiness, which was corroborated in-vivo with the decrease of key BBB transcripts in isolated blood vessels from hippocampi harvested from TiNP-treated mice. Titanium particles rapidly internalized into brain-like endothelial cells via caveolae-mediated endocytosis and macropinocytosis and induced pro-inflammatory reaction with increased expression of pro-inflammatory genes and proteins. Immune reaction was mediated partially by IL-1R and IL-6. In summary, we show that high levels of titanium accumulate in humans adjacent to orthopedic implants, and our in-vivo and in-vitro studies suggest it may be neurotoxic.

Quote Source:
https://www.sciencedirect.com/science/article/abs/pii/S0142961221003951

I keep pounding the table on Sintx coating being needed, at the very least, to reduce the amount of corrosive metal ions released peoples bodies from metal implants. Personally i say screw the coating and just go full Si3N4 implant! However a coating is better than nothing. Coating method Sintx has allows them to coat companies current inventory if the FDA cleared it.
On a different note, 3 more passenger planes experiences glitching on the 24th bring the total passenger plane emergency landings/crashes to 34 since December 22nd.

Electromagnetic fields, metal implant corrosion, and dis-ease it causes

https://i.imgur.com/nLg7SXT.jpg

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779

========================================

For continued coverage of significant Airplane malfunctions and why Sintx Si3N4 aerospace products are needed goto my research board. 34 passenger plane malfunctions since December 22nd..
https://investorshub.advfn.com/Bostons-research-43724

Here is a collection of my research going over multiple subjects including Sintx connections with Zimmer Biomet, Solventum, Morgan Ceramics, & NP Aerospace. Includes other research topics as well.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175357996

========================================

We already know Sintx and Morgan were working together. If there is going to be some sort of NP/Sintx merger, that just solidifies it. We also know Zimmer Biomet and Sintx have had a long standing relationship (going on 20 years) so as long as Sintx components for Arthroplasty are any good, Zimmer Biomet will come out from behind the curtain. With ZB comes ZimVie and I believe Solventum because of Bryan Hanson. Leaving only Cardinal Health which is suggested by Sintx hiring of Joseph Palomo who joined Sintx from Cardinal Health R&D division.

Morgan Ceramics = Aerospace products
Zimmer Biomet = Arthroplasty oriented products
ZimVie = Dental?
Solventum = Wound Care, Catheters, & possibly Cancer treatment products.
Ned Medical = Microspheres for cancer treatment
Cardinal Health = PPE & Medical protection apparel.
NP Aerospace = Armor plates & other possible products connected to TA&T.

========================================

Markets Si3n4/Sintx Ceramics can be used in (not comprehensive)

Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Cancer Treatment (microspheres) = $5-$15bn

Total = $330bn-340bn

Sources:
https://web.archive.org/web/2024040...ogger.blogspot.com/2011/05/whos-next.html?m=1
https://orthospinenews.com/2021/01/...y-2025-as-acquisitions-surge-says-globaldata/
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
https://www.youtube.com/watch?v=KeSa5vCj6Kw
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
https://www.youtube.com/watch?v=KeSa5vCj6Kw

👍️0

PioneerPhoenix73 5 días hace

Bingo! 🏆️ Greatest Post~Of~All-Time! 🏆️

“ Astonishingly, Sintx Technologies, despite 20 years of development and a complete absence of commercial revenue, has inexplicably failed to secure a single patent for its purportedly groundbreaking silicon nitride material. This begs the question: how can a company, boasting of being 'uniquely positioned to drive innovation' and possessing the 'only FDA-registered silicon nitride medical device manufacturing facility in the world,' fail to capitalize on a theoretical total addressable market exceeding $330 billion?

Their self-proclaimed expertise in this material, dating back to 1857 (a historical inaccuracy conveniently overlooked), has seemingly yielded zero tangible results. Instead of generating revenue, Sintx Technologies appears to have relied heavily on government grants and bursaries, raising concerns about the allocation of public funds.

To justify their stock price, investors are forced to indulge in a realm of fantastical, pseudo-scientific applications. Anecdotal evidence and fabricated narratives abound, with Sintx Technologies' silicon nitride miraculously solving every conceivable global crisis – from mitigating space weather to reversing the mythical 'Hutchinson Effect.'

However, the most comical aspect of this narrative is the delusion that their intellectual property possesses immense value, despite the glaring absence of any patent protection. The reality is far grimmer: Sintx Technologies faces imminent bankruptcy, dependent on the whims of government funding. Their 'revolutionary' material, lacking any exclusive rights, can be easily replicated by competitors at a fraction of the cost.

This case study serves as a cautionary tale, highlighting the perils of excessive hype, the dangers of relying on government subsidies, and the critical importance of intellectual property protection in the competitive landscape of modern materials science.”

👍️0

jimr1717 5 días hace

Bingo! 🏆️ Post~Of~The~Week! 🏆️

“ Astonishingly, Sintx Technologies, despite 20 years of development and a complete absence of commercial revenue, has inexplicably failed to secure a single patent for its purportedly groundbreaking silicon nitride material. This begs the question: how can a company, boasting of being 'uniquely positioned to drive innovation' and possessing the 'only FDA-registered silicon nitride medical device manufacturing facility in the world,' fail to capitalize on a theoretical total addressable market exceeding $330 billion?

Their self-proclaimed expertise in this material, dating back to 1857 (a historical inaccuracy conveniently overlooked), has seemingly yielded zero tangible results. Instead of generating revenue, Sintx Technologies appears to have relied heavily on government grants and bursaries, raising concerns about the allocation of public funds.

To justify their stock price, investors are forced to indulge in a realm of fantastical, pseudo-scientific applications. Anecdotal evidence and fabricated narratives abound, with Sintx Technologies' silicon nitride miraculously solving every conceivable global crisis – from mitigating space weather to reversing the mythical 'Hutchinson Effect.'

However, the most comical aspect of this narrative is the delusion that their intellectual property possesses immense value, despite the glaring absence of any patent protection. The reality is far grimmer: Sintx Technologies faces imminent bankruptcy, dependent on the whims of government funding. Their 'revolutionary' material, lacking any exclusive rights, can be easily replicated by competitors at a fraction of the cost.

This case study serves as a cautionary tale, highlighting the perils of excessive hype, the dangers of relying on government subsidies, and the critical importance of intellectual property protection in the competitive landscape of modern materials science.”

👍️0

jimr1717 5 días hace

Or perhaps they hired none and this is just another Fake It piece.
Anything to keep the public buying shares.
Just like the share buyback Pump.
It’s close to Two Buck Tuesday again.
No one is Fooled. Certainly not the institutions.

👍️0

joev2 5 días hace

Sonny hired for both? Afterall he wore numerous hats before and we all know how successful the company was then. I say, do it again!

👍️0

boston745 5 días hace

Potential neurotoxicity of titanium implants: Prospective, in-vivo and in-vitro study

Titanium dioxide (TiO2) is a frequently used biomaterial, particularly in orthopedic and dental implants, and it is considered an inert and benign compound. This has resulted in toxicological scrutiny for TiO2 in the past decade, with numerus studies showing potential pathologic downstream effects. Herein we describe case report of a 77-year-old male with subacute CNS dysfunction, secondary to breakdown of a titanium-based carotid stent and leading to blood levels 1000 times higher (3 ppm) than the reported normal.
Rats bearing titanium implants or intravascularly treated with TiO2 nanoparticles (TiNP) exhibited memory impairments. A human blood-brain barrier (BBB) in-vitro model exposed to TiNP showed paracellular leakiness, which was corroborated in-vivo with the decrease of key BBB transcripts in isolated blood vessels from hippocampi harvested from TiNP-treated mice. Titanium particles rapidly internalized into brain-like endothelial cells via caveolae-mediated endocytosis and macropinocytosis and induced pro-inflammatory reaction with increased expression of pro-inflammatory genes and proteins. Immune reaction was mediated partially by IL-1R and IL-6. In summary, we show that high levels of titanium accumulate in humans adjacent to orthopedic implants, and our in-vivo and in-vitro studies suggest it may be neurotoxic.
I keep pounding the table on Sintx coating being needed, at the very least, to reduce the amount of corrosive metal ions released peoples bodies from metal implants. Personally i say screw the coating and just go full Si3N4 implant but something is better than nothing. Coating method Sintx has allows them to coat companies current inventory if the FDA cleared it.
On a different note, 3 more passenger planes experiences glitching on the 24th bring the total passenger plane emergency landings/crashes to 34 since December 22nd.

Quote Source:
https://www.sciencedirect.com/science/article/abs/pii/S0142961221003951

Electromagnetic fields, metal implant corrosion, and dis-ease it causes

https://i.imgur.com/nLg7SXT.jpg

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779

========================================

For continued coverage of significant Airplane malfunctions and why Sintx Si3N4 aerospace products are needed goto my research board. 34 passenger plane malfunctions since December 22nd..
https://investorshub.advfn.com/Bostons-research-43724

Here is a collection of my research going over multiple subjects including Sintx connections with Zimmer Biomet, Solventum, Morgan Ceramics, & NP Aerospace. Includes other research topics as well.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175357996

========================================

We already know Sintx and Morgan were working together. If there is going to be some sort of NP/Sintx merger, that just solidifies it. We also know Zimmer Biomet and Sintx have had a long standing relationship (going on 20 years) so as long as Sintx components for Arthroplasty are any good, Zimmer Biomet will come out from behind the curtain. With ZB comes ZimVie and I believe Solventum because of Bryan Hanson. Leaving only Cardinal Health which is suggested by Sintx hiring of Joseph Palomo who joined Sintx from Cardinal Health R&D division.

Morgan Ceramics = Aerospace products
Zimmer Biomet = Arthroplasty oriented products
ZimVie = Dental?
Solventum = Wound Care, Catheters, & possibly Cancer treatment products.
Ned Medical = Microspheres for cancer treatment
Cardinal Health = PPE & Medical protection apparel.
NP Aerospace = Armor plates & other possible products connected to TA&T.

========================================

Markets Si3n4/Sintx Ceramics can be used in (not comprehensive)

Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Cancer Treatment (microspheres) = $5-$15bn

Total = $330bn-340bn

Sources:
https://web.archive.org/web/2024040...ogger.blogspot.com/2011/05/whos-next.html?m=1
https://orthospinenews.com/2021/01/...y-2025-as-acquisitions-surge-says-globaldata/
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
https://www.youtube.com/watch?v=KeSa5vCj6Kw
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
https://www.youtube.com/watch?v=KeSa5vCj6Kw

👍️0

Atlanta1 5 días hace

who are you and why are you speaking for Boston?

👍️0

FkItMkIt 5 días hace

Boston says, "Does the company not maintain its job listings on Linkedin? If it pulled those job postings off Linkedin aren't the positions likely filled? Isn't indeed.com known for leaving expired/filled job postings up?"

"2 week postings is commonly required for public listings before giving the position to a candidate a company already has in mind."

👍️0

Atlanta1 6 días hace

They are here:

https://www.indeed.com/cmp/Sintx/jobs

👍️0

boston745 6 días hace

👍️0

jimr1717 6 días hace

Atlanta, with zero doubt. The SINTX Deer Saver 6000© is capable of preventing this terrible thing as well as protecting them from getting hit by Tesla’s , all other cars, trains, boats and planes.

It will be a little bit before I can gather the future revenue numbers but please check my personal DD page 6 or 7 times a day.

👍️0

boston745 6 días hace

OMG can Sintx Si3n4 patented coating method help with Hutchison Effect causing metal implants to spontaneously fracture and other Hutchison Effect Phenomenon like jelly metal at the World Trade Center after 911? Could it even be used to reduce Teslas Whompy Wheel issue?

CASE SUMMARY
A 10-year-old boy presented with a 1-wk history of a tender bulge over the left temporo-parieto-occipital scalp. He had undergone a temporo-parieto-occipital titanium mesh cranioplasty 26 mo previously. He denied antecedent head trauma. Computerized tomography disclosed a perpendicular fissure in the titanium mesh, suggesting a diagnosis of spontaneous titanium mesh fracture. He underwent a second temporo-parieto-occipital cranioplasty and made an uneventful recovery. Three-dimensional modeling and finite element analyses were used to explore potential risk factors of titanium mesh fracture.
CONCLUSION
We report a case of spontaneous fracture of a titanium mesh cranioplasty implant. The current case and literature review indicate that titanium mesh implants should be well-anchored to the base of bony defects to prevent fatigue-induced fractures.
https://web.archive.org/web/20220714010044/https://www.tandfonline.com/doi/abs/10.1179/143289109X12494867167242?journalCode=ymri20&;

The single best example proving Hutchison Effect is real is a bible that fused into a steel column at the World Trade Center location. It was found months after the events of September 11th. The source of the image, which i've edited, is from the New York Times article and i link to the original article for verification if you goto the imgur post.

https://i.imgur.com/GE182an.jpeg

2. “Jelly Metal”. The sample, usually a cast aluminum bar, is seen to quiver as if made of jelly. On occasion, drops of what appear to be molten aluminum are seen to fall from the sample. The sample is on paper or cardboard which shows no sign of sensible heat. In one case, a common steel cutlery knife which had lain on top of an aluminum flat bar was found to have literally sunk several millimeters into the
aluminum bar. The knife appeared not to have been affected.
https://archive.org/details/g-hathaway-hutchison-metal-analysis/page/672/mode/2up

Materials characterisation of bizarre and catastrophic 'burst' failure in metal by 'Hutchison Effect'
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011976/

SINTX Technologies Secures Patent Allowance for Wide-Ranging Silicon Nitride Biomaterial Applications
Notice of Allowance for SINTX’s patent application no. 17/237,687, titled “Methods of Silicon Nitride Laser Cladding.”
method for laser bonding bioactive silicon nitride to various biomedical implant substrates, including titanium, alumina, zirconia, and advanced polymers like PEKK.
https://ir.sintx.com/news-events/press-releases/detail/244/sintx-technologies-secures-patent-allowance-for

=======================================

Hutchison Effect & Teslas Whompy Wheel issue

Jain is one of tens of thousands of Tesla owners who have experienced premature failures of suspension or steering parts, according to a Reuters review of thousands of Tesla documents. The chronic failures, many in relatively new vehicles, date back at least seven years and stretch across Tesla’s model lineup and across the globe, from China to the United States to Europe, according to the records and interviews with more than 20 customers and nine former Tesla managers or service technicians.

https://www.reuters.com/investigates/special-report/tesla-musk-steering-suspension/

The exact cause of the Hutchison Effect is unknown in public spheres as it is classified under national security. However the most likely culprit seems to be a combination of electromagnetic sources coming together in a way to change the makeup of metals leading to their rusting, softening, fracturing, complete breaking, even dustification. Keep in mind the degree of metal materials that are within our buildings and infrastructure...even in concrete. Maybe this is why we are seeing an increase in building and bridge collapses?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175056420

========================================

For continued coverage of significant Airplane malfunctions and why Sintx Si3N4 aerospace products are needed goto my research board. 31 passenger plane malfunctions since December 22nd..
https://investorshub.advfn.com/Bostons-research-43724

Here is a collection of my research going over multiple subjects including Sintx connections with Zimmer Biomet, Solventum, Morgan Ceramics, & NP Aerospace. Includes other research topics as well.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175357996

========================================

We already know Sintx and Morgan were working together. If there is going to be some sort of NP/Sintx merger, that just solidifies it. We also know Zimmer Biomet and Sintx have had a long standing relationship (going on 20 years) so as long as Sintx components for Arthroplasty are any good, Zimmer Biomet will come out from behind the curtain. With ZB comes ZimVie and I believe Solventum because of Bryan Hanson. Leaving only Cardinal Health which is suggested by Sintx hiring of Joseph Palomo who joined Sintx from Cardinal Health R&D division.

Morgan Ceramics = Aerospace products
Zimmer Biomet = Arthroplasty oriented products
ZimVie = Dental?
Solventum = Wound Care, Catheters, & possibly Cancer treatment products.
Ned Medical = Microspheres for cancer treatment
Cardinal Health = PPE & Medical protection apparel.
NP Aerospace = Armor plates & other possible products connected to TA&T.

========================================

Markets Si3n4/Sintx Ceramics can be used in (not comprehensive)

Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Cancer Treatment (microspheres) = $5-$15bn

Total = $330bn-340bn

Sources:
https://web.archive.org/web/2024040...ogger.blogspot.com/2011/05/whos-next.html?m=1
https://orthospinenews.com/2021/01/...y-2025-as-acquisitions-surge-says-globaldata/
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
https://www.youtube.com/watch?v=KeSa5vCj6Kw
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
https://www.youtube.com/watch?v=KeSa5vCj6Kw

👍️0

PioneerPhoenix73 6 días hace

Great Post Why Sintx Technologies Is Worthless & The Stock Should Be Trading At Zero !

Astonishingly, Sintx Technologies, despite 20 years of development and a complete absence of commercial revenue, has inexplicably failed to secure a single patent for its purportedly groundbreaking silicon nitride material. This begs the question: how can a company, boasting of being 'uniquely positioned to drive innovation' and possessing the 'only FDA-registered silicon nitride medical device manufacturing facility in the world,' fail to capitalize on a theoretical total addressable market exceeding $330 billion?

Their self-proclaimed expertise in this material, dating back to 1857 (a historical inaccuracy conveniently overlooked), has seemingly yielded zero tangible results. Instead of generating revenue, Sintx Technologies appears to have relied heavily on government grants and bursaries, raising concerns about the allocation of public funds.

To justify their stock price, investors are forced to indulge in a realm of fantastical, pseudo-scientific applications. Anecdotal evidence and fabricated narratives abound, with Sintx Technologies' silicon nitride miraculously solving every conceivable global crisis – from mitigating space weather to reversing the mythical 'Hutchinson Effect.'

However, the most comical aspect of this narrative is the delusion that their intellectual property possesses immense value, despite the glaring absence of any patent protection. The reality is far grimmer: Sintx Technologies faces imminent bankruptcy, dependent on the whims of government funding. Their 'revolutionary' material, lacking any exclusive rights, can be easily replicated by competitors at a fraction of the cost.

This case study serves as a cautionary tale, highlighting the perils of excessive hype, the dangers of relying on government subsidies, and the critical importance of intellectual property protection in the competitive landscape of modern materials science.

👍️0

Atlanta1 6 días hace

OMG - can Sonny help with this??????

GA wildlife officials warn of positive case of ‘zombie deer disease’, first in state

By Scott Flynn, WSBTV.com
January 23, 2025 at 3:30 pm EST

👍️0

jimr1717 7 días hace

With the recent death of someone in the US I have tried but I Can’t Stop Pounding the Table on this.
Sintx needs to get their Bird Flu 6000© into production ASAP.

I have calculated all of the numbers for them to get 3/4 of a billion Bird flu 6000© masks made and those include masks for chickens.

The shareholders are used to the company printing shares and just reverse splitting the stock. What’s another reverse split.

If you have a few days please check out my personal page with my extensive DD calculations on this revenue.
You will find it astounding.

https://www.cdc.gov/media/releases/2025/m0106-h5-birdflu-death.html

👍️0

boston745 7 días hace

Lets consider some other positive moves which recently includes trying to hire CFO & HR manager suggesting the company is getting ready to expand again.

First was the buyback announcement of up to 20% which should be completed by Q2 or early Q3 2025 based on the use of the word "several" which implies more than 2 but not very many. 20% of the OS means that the float would drop to about 1m shares. I suspect that they bought back the majority of the shares on the day of the announcement given the sheer volume of shares traded.

SINTX Technologies Announces Stock Repurchase Program

Board of Directors has authorized a stock repurchase program to buy back up to $500,000 of the company’s outstanding common stock over the next several quarters which equates to about 20% of total outstanding shares.

Next they announced the hiring of Mr Honigblum as Chief Strategy Officer. Mr Honigblum aided Sintx in raising funds over almost the entire time it was a private entity stopping as soon as it went public. The fact that he is back and that the employee share plan was expanded, conveniently, suggests that hes going to aid in SINT valuation better reflecting the value of its tech and be rewarded for his years of service via issued shares.

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

in this role, Mr. Honigblum will oversee driving corporate strategy to support SINTX’s growth initiatives and enhancing investor relations.

Next thing to consider is Lind Partners Series E & F warrants. Specifically its Series F warrants. Those warrants have a strike price of $50 and expire August 2025. Thus for Lind to be able to utilize those warrants, one might think that SINT sees a price pump over $50 before August. As i already indicated, a float of 1m shares at that price, is only a valuation of $50m or so which Sintx is easily worth more than at current time based on its IP and partners. Hell its partnership with NedMedical is worth more than $50m by itself considering the microsphere cancer market is worth $5-15b. There are 3 products that could be released in a 2-5 year period for which they should already be a year into and product one being the easiest to bring to market. Products 2 & 3 will require trials and alot of capital.

The Class E and Class F Warrants were immediately exercisable at a price of $50.00 per share. The Class E Warrants expire five years from the date of issuance and the Class F Warrants expire eighteen months from the date of issuance.
Then of course there is NedMedical a wildcard in this. As far as i can tell so far, NedMedical has only raised a 1.8m seed round and was due for a Series A sometime Q1 2025 according to its CEO. Given Sintx and NedMedical's partnership, there is two distinct possibilities here, especially considering the product being created only works with Sintx ceramic microsphere technology. First Sintx could take an investment stake in NedMedical acquiring a portion of the company. The other is Sintx merges NedMedical into it as a subsidiary. Both of these scenarios require significant increase in valuation and cash for Sintx to manager either say a 20% stake or 50+% merger with Ned.

Given a Zimmer Biomet's board member's, i think son, is on Ned Medical's scientific board only supports these scenarios. Arthur Higgns, i believe to be dad, and NedMedical's Dr Luke Higgins, i believe to be the son.

What all this supports is SINT price increasing significantly this year if the August warrants are to be used and the fact that NedMedical is supposed to raise funds. In odd synchronicity, NedMedical is located outside of Boston which tickles me like the band Boston and its song AM(an)DA. Lots of reasons to be bullish but obviously timing is everything. Outside of calling a Tesla running a redlight and a solar storm a month before it happened, i dont have the greatest track record of predicting when something will happen. Still waiting for ZB to officially announce at least a partnership with Sintx.

Anyone can verify this factual information at the following links. My analysis is obviously mine but can be verified in previous posts to look for consistency as new information arises.

Sources:
https://ir.sintx.com/news-events/press-releases/detail/241/sintx-technologies-announces-stock-repurchase-program
https://ir.sintx.com/news-events/press-releases/detail/242/sintx-technologies-appoints-gregg-r-honigblum-as-chief
https://www.sec.gov/ix?doc=/Archives/edgar/data/1269026/000149315224044728/form10-q.htm
https://investor.zimmerbiomet.com/corporate-governance/board-of-directors/arthur-j-higgins
https://nedmedical.com/ned-medical-launches-world-class-scientific-advisory-board/

========================================

For continued coverage of significant Airplane malfunctions and why Sintx Si3N4 aerospace products are needed goto my research board. 31 passenger plane malfunctions since December 22nd..
https://investorshub.advfn.com/Bostons-research-43724

Here is a collection of my research going over multiple subjects including Sintx connections with Zimmer Biomet, Solventum, Morgan Ceramics, & NP Aerospace. Includes other research topics as well.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175357996

========================================

We already know Sintx and Morgan were working together. If there is going to be some sort of NP/Sintx merger, that just solidifies it. We also know Zimmer Biomet and Sintx have had a long standing relationship (going on 20 years) so as long as Sintx components for Arthroplasty are any good, Zimmer Biomet will come out from behind the curtain. With ZB comes ZimVie and I believe Solventum because of Bryan Hanson. Leaving only Cardinal Health which is suggested by Sintx hiring of Joseph Palomo who joined Sintx from Cardinal Health R&D division.

Morgan Ceramics = Aerospace products
Zimmer Biomet = Arthroplasty oriented products
ZimVie = Dental?
Solventum = Wound Care, Catheters, & possibly Cancer treatment products.
Ned Medical = Microspheres for cancer treatment
Cardinal Health = PPE & Medical protection apparel.
NP Aerospace = Armor plates & other possible products connected to TA&T.

========================================

Markets Si3n4/Sintx Ceramics can be used in (not comprehensive)

Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Cancer Treatment (microspheres) = $5-$15bn

Total = $330bn-340bn

Sources:
https://web.archive.org/web/2024040...ogger.blogspot.com/2011/05/whos-next.html?m=1
https://orthospinenews.com/2021/01/...y-2025-as-acquisitions-surge-says-globaldata/
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
https://www.youtube.com/watch?v=KeSa5vCj6Kw
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
https://www.youtube.com/watch?v=KeSa5vCj6Kw

👍️0

jimr1717 7 días hace

Another deer runs into headlights.

I keep pounding the table on this topic.
Every single auto manufacturer needs to start coating their headlight lenses with SINTX Deer Saver 6000©.
There seems to be a 27 fold increase in this since the last quarter of solar cycle 2z5A.
I am speculating that once solar cycle 2z5B arrives this tragic collision will increase.

Once the Deer Saver 6000© hits the market there will be a massive increase in SINTX revenue.
I will have a complete break down shortly on this gigantic revenue on my personal page soon.

👍️0

PioneerPhoenix73 7 días hace

SintX Technologies on verge of bankruptcy ? I.P is worthless and products are not selling.

SINTX Technologies, Inc. has been hinting at a major restructuring plan, and frankly, it sounds like they're facing a serious uphill battle. It seems like their basically throwing in the towel on their Utah headquarters and moving to Boise to cut costs. It seems like their silicon nitride material just isn't selling, and they're running out of cash fast – only eight months of operating expenses left!

The CEO has been giving clues that if they move it would be all about streamlining and focusing on the most important stuff, but it sounds like they're really just trying to stay afloat. Closing the Utah office means layoffs, which is never easy. Hopefully, they're taking care of their employees during this tough time.

I'm not sure what the future holds for SINTX, but this restructuring in my opinion definitely feels like a last-ditch effort to avoid bankruptcy. It'll be interesting to see if they can turn things around and actually succeed in Boise our any other place.

A note for technical traders in SintX technologies the Stochastic Oscillator is moving up while the Relative Strength Index is moving down. The head and shoulder pattern is indicating more head then shoulder with a rear gap that is to tight to be filled. I would stay away and wait to see what happens after bankruptcy.

SINTX Technologies' odds of distress is above 97% at this time. It has very high probability of going through financial hardship in the upcoming years. Probability of financial unrest prediction helps decision makers evaluate SINTX Technologies' chance of financial distress in relation to its going-concern outlook and evaluation. All items used in analyzing the odds of distress are taken from the SINTX balance sheet, as well as cash flow and income statements available from the company's most recent filings indicate bankruptcy is imminent,

👍️0

jimr1717 1 semana hace

This is consistent with my analysis looking at the 5 year chart from $60,000 to 3 bucks.

Please follow my entailed analysis of my 9 year forecast on my personal page.

You can find it under either the “Fake it Scam”
or “Tax loss of the century” files.

https://ih.advfn.com/stock-market/NASDAQ/sintx-technologies-SINT/chart/streaming

👍 1 🔥 1

jimr1717 1 semana hace

SINTQ? But but wait the insiders haven’t had time to sell their freshly given gifted shares yet?
How’s that Fake it buy back coming along?

Perhaps they will build a facility large enough to apply Bridge Fixer 6000© to the beams.

👍️0

boston745 1 semana hace

👍️0

boston745 1 semana hace

As i previously posted, i thought that it was possible, in theory, that Sintx Si3n4 could disrupt the Hutchison Effect because of its ability to reduce corrosion when coated on metals. Since ive established the Hutchison Effect was seen during the events of September 11th, explaining how a bible had fused into a steel column, image below, without suffering heat damage and that the building turned mostly to dust, we can look at other evidence seen that day...really sometime later. See, as it turns out, and for reasons not explained, adjacent building suffered significant corrosion and rusting. The Bankers Trust building, which also suffered damage on 911, had suffer significant rusting of at least one of its central support columns according to Dr Judy Wood. Its almost like the Hutchison Effect causes some sort accelerated corrosion which lead to this buildings enhanced corrosion and the towers turning to dust. This is not something airplanes can cause, so a different mechanism was used that day. Woods, for reasons i do not understand, talks about free energy, but doesnt provide any evidence of that. Sure, directed energy weapon could have been used but that has nothing to do with the concept of free energy which she uses interchangeably. Free energy is part of the technocracy propaganda that promotes a technotopia of the future, as if such a thing were possible. No, a technotopia is not possible as long as the earths magnetic field continues to weaken and the chaotic EM energy continues to wreak havoc on modern technology.

Anyways, Si3N4 can slow the metal corrosion process in the body, so as i indicated it could slow down the process of corrosion when exposed to the Hutchison Effect. If so, it could be used to help with Teslas Whompy Wheel issue if coated on the underbelly, although thats likely expensive. Still this is all speculative.

Bankers Trust Building Rust & source video:

https://i.imgur.com/9eo8ooa.jpeg

it looks like it's been at the
bottom of the ocean for 100
years extreme degradation and it makes
one wonder is the was the building
continuing to disintegrate and that's
why they had to take it down after they
repaired it

Phenomenon of Hutchison Effect - Crumbling is akin to Dustification

https://i.imgur.com/IO78Et9.jpeg

https://www.youtube.com/watch?v=L5zbTnfGe3E

Bible Fused into steel column

https://imgur.com/a/oDnuleU

Towers turned moslty to dust...aka Dustication
https://www.youtube.com/watch?v=x2IMiQzFu6I

👍️0

jimr1717 1 semana hace

Atlanta with absolutely no doubt.

The SINTX Glitch Fixer 6000©. is hands down your answer.
Elon is looking at dipping all of the Tesla computer boards in the Glitch Fixer 6000©.

I have the expected revenue generating calculations on my personal DD page and it’s listed just below the Condom speculation numbers.
Hope this helps.

👍️0

boston745 1 semana hace

This is consistent with my analysis. 12 PT is consistent with the downtrend continuing but fills the gap. Higher is needed to breakout of current trend. A big new contract will send this well over 12 and should help Lind exercise its Series F warrants before August. Despite whats being claimed on ST, i do not see it happening this week. The following post occurred after it was mentioned that Sintx is hiring CFO & head of HR which seems odd after all their cutbacks in staffing unless they are about to kick off hiring again. For years now, CFO duties have been handled by the CEO.

littleguyfinance
3:12 AM
@amda something good is coming. Several positive signs are pointing to a new day for this company. I’m expecting a big new contract soon. My 2025 SP target is $12. We could see much higher.

https://stocktwits.com/littleguyfinance/message/600071848

Lets consider some other positive moves.
First was the buyback announcement of up to 20% which should be completed by Q2 or early Q3 2025 based on the use of the word "several" which implies more than 2 but not very many. 20% of the OS means that the float would drop to about 1m shares. I suspect that they bought back the majority of the shares on the day of the announcement given the sheer volume of shares traded.

SINTX Technologies Announces Stock Repurchase Program

Board of Directors has authorized a stock repurchase program to buy back up to $500,000 of the company’s outstanding common stock over the next several quarters which equates to about 20% of total outstanding shares.

Next they announced the hiring of Mr Honigblum as Chief Strategy Officer. Mr Honigblum aided Sintx in raising funds over almost the entire time it was a private entity stopping as soon as it went public. The fact that he is back and that the employee share plan was expanded, conveniently, suggests that hes going to aid in SINT valuation better reflecting the value of its tech and be rewarded for his years of service via issued shares.

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

n this role, Mr. Honigblum will oversee driving corporate strategy to support SINTX’s growth initiatives and enhancing investor relations.

Next thing to consider is Lind Partners Series E & F warrants. Specifically its Series F warrants. Those warrants have a strike price of $50 and expire August 2025. Thus for Lind to be able to utilize those warrants, one might think that SINT sees a price pump over $50 before August. As i already indicated, a float of 1m shares at that price, is only a valuation of $50m or so which Sintx is easily worth more than at current time based on its IP and partners. Hell its partnership with NedMedical is worth more than $50m by itself considering the microsphere cancer market is worth $5-15b. There are 3 products that could be released in a 2-5 year period for which they should already be a year into and product one being the easiest to bring to market. Products 2 & 3 will require trials and alot of capital.

The Class E and Class F Warrants were immediately exercisable at a price of $50.00 per share. The Class E Warrants expire five years from the date of issuance and the Class F Warrants expire eighteen months from the date of issuance.

Then of course there is NedMedical a wildcard in this. As far as i can tell so far, NedMedical has only raised a 1.8m seed round and was due for a Series A sometime Q1 2025 according to its CEO. Given Sintx and NedMedical's partnership, there is two distinct possibilities here, especially considering the product being created only works with Sintx ceramic microsphere technology. First Sintx could take an investment stake in NedMedical acquiring a portion of the company. The other is Sintx merges NedMedical into it as a subsidiary. Both of these scenarios require significant increase in valuation and cash for Sintx to manager either say a 20% stake or 50+% merger with Ned.

Given a Zimmer Biomet's board member's, i think son, is on Ned Medical's scientific board only supports these scenarios. Arthur Higgns, i believe to be dad, and NedMedical's Dr Luke Higgins, i believe to be the son.

What all this supports is SINT price increasing significantly this year if the August warrants are to be used and the fact that NedMedical is supposed to raise funds. In odd synchronicity, NedMedical is located outside of Boston which tickles me. Lots of reasons to be bullish but obviously timing is everything. Outside of calling a Tesla running a redlight and a solar storm a month before it happened, i dont have the greatest track record of predicting when something will happen. Still waiting for ZB to officially announce at least a partnership with Sintx.

Anyone can verify this factual information at the following links. My analysis is obviously mine but can be verified in previous posts to look for consistency as new information arises.

Sources:
https://ir.sintx.com/news-events/press-releases/detail/241/sintx-technologies-announces-stock-repurchase-program
https://ir.sintx.com/news-events/press-releases/detail/242/sintx-technologies-appoints-gregg-r-honigblum-as-chief
https://www.sec.gov/ix?doc=/Archives/edgar/data/1269026/000149315224044728/form10-q.htm
https://investor.zimmerbiomet.com/corporate-governance/board-of-directors/arthur-j-higgins
https://nedmedical.com/ned-medical-launches-world-class-scientific-advisory-board/

👍️0

Atlanta1 1 semana hace

I have several websites going haywire today, including LinkedIn. Can SINTX's pixie dust help?

👍️0

jimr1717 1 semana hace

Fascinating find. Was there a bible embedded into the boat also?

👍️0

PioneerPhoenix73 1 semana hace

Hutchison Effect caused Noahs Ark to sink could Sintx Si3N4 disrupt the effect?

When you examine isolated incidents it is easier to dismiss the problem of the Hutchison Effect. However when you examine them in aggregate you start to see a pattern indicating it's real.

The recent discovery of anomalous metallic artifacts, such as a 'petrified rivet' and 'washer structures,' at the alleged site of Noah's Ark presents a compelling case for the potential impact of the Hutchinson Effect.

Evidence suggests the Ark may have experienced catastrophic material failure, characterized by the fusion of dissimilar metals and spontaneous deformation. This aligns with the known effects of the Hutchinson Effect, a phenomenon involving anomalous interactions between electromagnetic fields and matter.

This incident underscores the critical importance of advanced materials science and protective technologies. Sintx Technologies, with its expertise in advanced materials like silicon nitride, could have potentially mitigated this disaster through the application of protective coatings.

This example, along with other documented instances such as the Tesla vehicle incident depicted in the film 'Live Action Aladdin,' the 9/11 World Trade Center collapse, and various instances of aircraft and bridge failures, collectively point towards the critical need for further research and development in materials science to prevent future catastrophic events. Further analysis and discussion on these matters will follow.

👍️0

boston745 1 semana hace

I do not know why, but there does not seem to be studies connecting immune responses/disease connected to the combination of EMFs like indicated in this first study and the next article listing immune disorders associated with metal implants. In reality its likely that metal ions/metal implants themselves coupled with natural/man-made EMF sources that causing worsening autoimmune issues. You do not necessarily need to have metal implants to worsen this problem. For instance, multi-vitamins could worsen this by aiding in increasing magnetic metals, which are necessary in small quantities, in the body. Thus the only solution to this problem is to switch to ceramics and plastics in the greater Ortho-Dental market. Currently there is only one ceramic material that could replace metal components, or coat them to reduce ion release, and that material is Sintx Si3N4. However to accomplish this Sintx must successfully develop methods of 3D printing to address Si3N4's one major drawback, its modulus of elasticity. A collaboration with 3DCeram Sinto began last year for just this purpose.

Disturbance of the immune system by electromagnetic fields—A potentially underlying cause for cellular damage and tissue repair reduction which could lead to disease and impairment
A number of papers dealing with the effects of modern, man-made electromagnetic fields (EMFs) on the immune system are summarized in the present review. EMFs disturb immune function through stimulation of various allergic and inflammatory responses, as well as effects on tissue repair processes. Such disturbances increase the risks for various diseases, including cancer. These and the EMF effects on other biological processes (e.g. DNA damage, neurological effects, etc.) are now widely reported to occur at exposure levels significantly below most current national and international safety limits. Obviously, biologically based exposure standards are needed to prevent disruption of normal body processes and potential adverse health effects of chronic exposure.
Autoimmune diseases associated with metal in medical and dental implants and devices

While numerous health conditions have been related to the presence of metals in the body, scientific research has clearly shown that autoimmune disease can be associated with metals used in dentistry and medicine, including metals in medical and dental implants, devices, and adjuvants (substances added to vaccines such as aluminum and mercury). Several of the autoimmune diseases studied for their relation to metal in medical and dental implants, devices, and adjuvants include the following:

Quote Sources:

https://www.sciencedirect.com/science/article/abs/pii/S0928468009000352
https://implante.institute/blog/autoimmune-diseases-and-metal-implants-and-devices/407

========================================

Electromagnetic fields, metal implant corrosion, and dis-ease it causes

https://i.imgur.com/nLg7SXT.jpg

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779

========================================

Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application

examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm

========================================

Extra information on the status of a Si3n4 based hip implant:

Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/

👍️0

jimr1717 1 semana hace

After reading your DD here I still think that Musk’s answer is to write a check and start dipping his cars in the SINTX Saver3000 ©.

It’s a no brainer. Zero Incarceration for DUI.

No need to waste your money on car insurance.

No more car accidents. No plane failures, no migraines from tooth implants no ski lift failures, no bridge failures.

Please check out my personal page for a complete update on this topic later in the week.

👍️0

jimr1717 1 semana hace

It’s my opinion that SINTX should not only send you a Christmas card, they should send you a gift.
Anyone that has held this Fake it scam for 9 years through 3 or 4 Reverse Splits is deserving of such.

At minimum I think they should send you a case of Ozone Saver3000 ©.

👍️0

boston745 1 semana hace

👍️0

Datos

Noticias

Herramientas

Mercados

Descubrir

Hot Features

Follow Feed

Flujo de Opciones

Monitor

SiNtx Technologies Inc (SINT)

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

SINT Noticias

Form 8-K - Current report

SINTX Technologies Secures Patent Allowance for Wide-Ranging Silicon Nitride Biomaterial Applications

Form 8-K - Current report

Form 8-K - Current report

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

Form 8-K - Current report

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

Form 8-K - Current report

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form DEF 14A - Other definitive proxy statements

SINTX Technologies Provides Positive Strategic Business Update for Q3 2024

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

SINT Discussion

Su Consulta Reciente

Empresa

Negocios

Popular

Obtener la aplicación

Tendencias Ahora

Listas Principales

Datos

Noticias

Herramientas

Mercados

Descubrir

Hot Features

Follow Feed

Flujo de Opciones

Monitor

SiNtx Technologies Inc (SINT) Noticias

SiNtx Technologies Inc (SINT)

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

SINT Noticias

Form 8-K - Current report

SINTX Technologies Secures Patent Allowance for Wide-Ranging Silicon Nitride Biomaterial Applications

Form 8-K - Current report

Form 8-K - Current report

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

Form 8-K - Current report

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

Form 8-K - Current report

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form DEF 14A - Other definitive proxy statements

SINTX Technologies Provides Positive Strategic Business Update for Q3 2024

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

SINT Discussion

Su Consulta Reciente

Empresa

Negocios

Popular

Obtener la aplicación

Quitar anuncios